JP2005526847A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526847A5
JP2005526847A5 JP2004503043A JP2004503043A JP2005526847A5 JP 2005526847 A5 JP2005526847 A5 JP 2005526847A5 JP 2004503043 A JP2004503043 A JP 2004503043A JP 2004503043 A JP2004503043 A JP 2004503043A JP 2005526847 A5 JP2005526847 A5 JP 2005526847A5
Authority
JP
Japan
Prior art keywords
antigen
composition
carrier protein
composition according
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004503043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526847A (ja
JP4662537B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/002648 external-priority patent/WO2003094960A2/en
Publication of JP2005526847A publication Critical patent/JP2005526847A/ja
Publication of JP2005526847A5 publication Critical patent/JP2005526847A5/ja
Application granted granted Critical
Publication of JP4662537B2 publication Critical patent/JP4662537B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004503043A 2002-05-14 2003-05-14 細菌性髄膜炎に関する粘膜組合せワクチン Expired - Fee Related JP4662537B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38067502P 2002-05-14 2002-05-14
PCT/IB2003/002648 WO2003094960A2 (en) 2002-05-14 2003-05-14 Mucosal combination vaccines for bacterial meningitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010143117A Division JP2010202672A (ja) 2002-05-14 2010-06-23 細菌性髄膜炎に関する粘膜組合せワクチン

Publications (3)

Publication Number Publication Date
JP2005526847A JP2005526847A (ja) 2005-09-08
JP2005526847A5 true JP2005526847A5 (https=) 2006-06-15
JP4662537B2 JP4662537B2 (ja) 2011-03-30

Family

ID=29420626

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004503043A Expired - Fee Related JP4662537B2 (ja) 2002-05-14 2003-05-14 細菌性髄膜炎に関する粘膜組合せワクチン
JP2010143117A Withdrawn JP2010202672A (ja) 2002-05-14 2010-06-23 細菌性髄膜炎に関する粘膜組合せワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010143117A Withdrawn JP2010202672A (ja) 2002-05-14 2010-06-23 細菌性髄膜炎に関する粘膜組合せワクチン

Country Status (12)

Country Link
US (2) US20060147466A1 (https=)
EP (1) EP1506007B1 (https=)
JP (2) JP4662537B2 (https=)
CN (2) CN1816350B (https=)
AT (1) ATE513560T1 (https=)
AU (1) AU2003239744B2 (https=)
BR (1) BR0310042A (https=)
CA (1) CA2485999C (https=)
MX (1) MXPA04011248A (https=)
NZ (1) NZ536859A (https=)
RU (1) RU2378008C2 (https=)
WO (1) WO2003094960A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0302218D0 (en) 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
EP2172213B1 (en) 2003-01-30 2013-04-03 Novartis AG Injectable vaccines against multiple meningococcal serogroups
AU2011224064A1 (en) * 2003-10-02 2011-10-06 Novartis Vaccines And Diagnostics S.R.L. Liquid vaccines for multiple meningococcal serogroups
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
NZ550533A (en) 2004-04-30 2010-02-26 Novartis Vaccines & Diagnostic Meningococcal conjugate vaccination comprising N. meningitidis and diphtheria toxin
EP2269638A3 (en) * 2004-05-28 2012-06-13 GlaxoSmithKline Biologicals S.A. Vaccine compositions comprising virosomes and a saponin adjuvant
PE20110072A1 (es) 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
WO2008101349A1 (en) 2007-02-23 2008-08-28 Her Majesty The Queen, In Right Of Canada, As Repesented By The Minister Of National Defence Recombinant viral vectors for prevention and protection against alphavirus infection
CN101249261B (zh) * 2008-03-18 2010-10-27 中国疾病预防控制中心病毒病预防控制所 一种肾综合征出血热粘膜免疫疫苗及其制备方法
EP2440251A4 (en) * 2009-06-09 2013-01-16 Defyrus Inc INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
CN107913396B (zh) 2010-08-23 2022-03-08 惠氏有限责任公司 脑膜炎萘瑟氏菌rLP2086抗原的稳定制剂
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
CN103648489A (zh) 2011-05-11 2014-03-19 儿童医疗中心有限公司 多抗原提呈免疫原性组合物及其方法和用途
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY198910A (en) 2012-03-09 2023-10-02 Pfizer Neisseria meningitidis compositions and methods thereof
US11576958B2 (en) 2013-02-07 2023-02-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
CN104383531A (zh) * 2014-11-18 2015-03-04 北京智飞绿竹生物制药有限公司 预防儿童脑膜炎的联合疫苗及其制备方法
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN105031644A (zh) * 2015-06-25 2015-11-11 中国科学院过程工程研究所 一种疫苗佐剂及含该疫苗佐剂的疫苗组合物和疫苗制剂
CN106606775A (zh) * 2015-10-27 2017-05-03 格里菲斯大学 脂质体a群链球菌疫苗
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
AU2018243910B2 (en) 2017-03-28 2025-04-10 The Children's Medical Center Corporation A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2018227177A1 (en) 2017-06-10 2018-12-13 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
MX2019015524A (es) 2017-06-23 2020-09-10 Univ Maryland Composiciones inmunogenicas.
SG11202101973YA (en) 2018-09-12 2021-03-30 Childrens Medical Ct Corp Pneumococcal fusion protein vaccines
CN112969474A (zh) 2018-09-12 2021-06-15 艾芬尼维克斯公司 多价肺炎球菌疫苗
RU2704452C1 (ru) * 2019-04-22 2019-10-28 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения вакцины гемофильной тип b конъюгированной
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
MX2024002779A (es) 2021-09-09 2024-06-11 Affinivax Inc Vacunas neumocócicas multivalentes.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
HU9201966D0 (en) * 1989-12-14 1992-10-28 Ca Nat Research Council An improved vaccine of meningococcus-polysaccharide conjunction
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US6884435B1 (en) * 1997-01-30 2005-04-26 Chiron Corporation Microparticles with adsorbent surfaces, methods of making same, and uses thereof
US6818222B1 (en) * 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
GB9713156D0 (en) * 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
WO1998058670A1 (en) * 1997-06-24 1998-12-30 Chiron Corporation Methods of immunizing adults using anti-meningococcal vaccine compositions
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
DE69939943D1 (de) * 1998-10-21 2009-01-02 Kitasato Inst Attenuierte Toxine als Adjuvantien
ATE459373T1 (de) * 1999-03-19 2010-03-15 Glaxosmithkline Biolog Sa Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
GB9923060D0 (en) * 1999-09-29 1999-12-01 Chiron Spa Vaccine
CA2400468C (en) * 2000-02-15 2012-12-18 Intellivax International Inc. Proteosome influenza vaccine
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
CZ20024224A3 (cs) * 2000-06-29 2003-05-14 Glaxosmithkline Biologicals S. A. Farmaceutický prostředek
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2439111A1 (en) * 2001-04-05 2002-10-17 Chiron Corporation Mucosal boosting following parenteral priming
GB0129007D0 (en) * 2001-12-04 2002-01-23 Chiron Spa Adjuvanted antigenic meningococcal compositions
WO2003059385A2 (en) * 2002-01-14 2003-07-24 Chiron Corporation Hiv vaccine and method of use
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery

Similar Documents

Publication Publication Date Title
JP2005526847A5 (https=)
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
JP2004501873A5 (https=)
JP5698770B2 (ja) 担体タンパク質への細菌多糖のコンジュゲーションプロセス
JP4870895B2 (ja) ワクチン組成物
JP2007516219A5 (https=)
RU2005127200A (ru) Менингококковые вакцины для введения через слизистую оболочку
TWI281403B (en) Vaccine
JP7132954B2 (ja) 改善された免疫原性及び結合活性を提供する２価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン
JP2011042693A5 (https=)
JP2005504718A5 (https=)
JP2005508849A5 (https=)
HRP20110685T1 (hr) Cjepivo od konjugata pneumokoknog polisaharida
JP2020514326A (ja) 肺炎連鎖球菌多糖−タンパク質コンジュゲートの免疫原性の増強
ATE552844T1 (de) Injizierbarer impfstoff gegen multiple meningokokken-serogruppen
RU2009134033A (ru) Жидкие вакцины для множественных серогрупп менингококков
JP2008543907A5 (https=)
JP2010163453A5 (https=)
JP2008543908A5 (https=)
JP2008526939A5 (https=)
JP2020523323A5 (https=)
JP2007507487A5 (https=)
JP2006528936A5 (https=)
RU2008112289A (ru) Множественная вакцинация, включающая менингококки серогруппы с
JP2014507451A (ja) コンジュゲーション方法